Michel Sabé

1.8k total citations · 3 hit papers
44 papers, 1.1k citations indexed

About

Michel Sabé is a scholar working on Psychiatry and Mental health, Clinical Psychology and Experimental and Cognitive Psychology. According to data from OpenAlex, Michel Sabé has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 15 papers in Clinical Psychology and 9 papers in Experimental and Cognitive Psychology. Recurrent topics in Michel Sabé's work include Schizophrenia research and treatment (15 papers), Psychedelics and Drug Studies (7 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Michel Sabé is often cited by papers focused on Schizophrenia research and treatment (15 papers), Psychedelics and Drug Studies (7 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Michel Sabé collaborates with scholars based in Switzerland, United States and Germany. Michel Sabé's co-authors include Stefan Kaiser, Othman Sentissi, Marco Solmi, Chaomei Chen, Armida Mucci, Silvana Galderisi, Alessio Crippa, Peter Falkai, Giulia Maria Giordano and Wolfgang Gäebel and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Michel Sabé

38 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EPA guidance on assessment of negative symptoms in schizophrenia

2021 148 citations Silvana Galderisi, Armida Mucci et al. profile →
Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends

2022 129 citations Michel Sabé, Stefan Kaiser et al. Neuroscience & Biobehavioral Reviews profile →
EPA guidance on treatment of negative symptoms in schizophrenia

2021 122 citations Silvana Galderisi, Stefan Kaiser et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michel Sabé Switzerland	18	482	247	196	168	106	44	1.1k
Panagiotis Ferentinos Greece	22	519 1.1×	283 1.1×	203 1.0×	126 0.8×	49 0.5×	116	1.5k
Philippos Gourzis Greece	21	458 1.0×	262 1.1×	95 0.5×	120 0.7×	79 0.7×	80	1.4k
Yong Sik Kim South Korea	25	749 1.6×	358 1.4×	302 1.5×	181 1.1×	74 0.7×	122	2.0k
Jinguo Zhai China	19	415 0.9×	121 0.5×	89 0.5×	295 1.8×	64 0.6×	55	971
C. Even France	17	439 0.9×	228 0.9×	163 0.8×	103 0.6×	34 0.3×	49	1.1k
Jae Seung Chang South Korea	22	735 1.5×	193 0.8×	132 0.7×	177 1.1×	88 0.8×	77	1.5k
P Andlin‐Sobocki Sweden	10	456 0.9×	218 0.9×	154 0.8×	103 0.6×	37 0.3×	14	1.3k
Stephan Köhler Germany	19	307 0.6×	260 1.1×	259 1.3×	129 0.8×	28 0.3×	71	1.4k
Kesavan Muralidharan India	18	492 1.0×	195 0.8×	61 0.3×	155 0.9×	42 0.4×	95	1.0k
Helge Müller Germany	18	426 0.9×	290 1.2×	83 0.4×	355 2.1×	28 0.3×	76	1.4k

Countries citing papers authored by Michel Sabé

Since Specialization

Citations

This map shows the geographic impact of Michel Sabé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Sabé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Sabé more than expected).

Fields of papers citing papers by Michel Sabé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Sabé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Sabé. The network helps show where Michel Sabé may publish in the future.

Co-authorship network of co-authors of Michel Sabé

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Sabé. A scholar is included among the top collaborators of Michel Sabé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Sabé. Michel Sabé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ng, Jeremy Y., Ana Patricia Ayala, Michel Sabé, et al.. (2025). Guidance for the reporting of bibliometric analyses: A scoping review. Quantitative Science Studies. 6. 988–1001. 1 indexed citations

Rochas, Vincent, Matthias Kirschner, Michel Sabé, et al.. (2025). EEG microstates, acute phase negative symptoms of schizophrenia and antipsychotic treatment response. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 141. 111466–111466.

Sabé, Michel, Gabriel Thorens, Daniele Zullino, et al.. (2025). Treatment of depressive and negative symptoms in individuals with schizoaffective disorders using serotoninergic psychedelics: a case report. Journal of Psychiatry and Neuroscience. 50(4). E234–E236.

Sabé, Michel, et al.. (2025). Resting-state EEG and MEG gamma frequencies in schizophrenia: a systematic review and exploratory power-spectrum meta-analysis. Schizophrenia. 11(1). 48–48. 2 indexed citations

Thorens, Gabriel, Katrin H. Preller, Kerem Böge, et al.. (2025). Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review. Asian Journal of Psychiatry. 110. 104604–104604.

Sabé, Michel, Joshua Hyde, Alessio Crippa, et al.. (2024). Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation Across Mental Disorders. JAMA Network Open. 7(5). e2412616–e2412616. 22 indexed citations

Georgiadis, Foivos, Janis Brakowski, Michel Sabé, et al.. (2024). Negative Symptoms and Their Associations With Other Clinical Variables and Working Memory Across the Schizophrenia Spectrum and Bipolar Disorder. Schizophrenia Bulletin Open. 5(1). sgae024–sgae024. 2 indexed citations

Saccaro, Luigi Francesco, Clément Mallet, Alexandre Wullschleger, & Michel Sabé. (2024). Psychiatric manifestations in moyamoya disease: more than a puff of smoke? a systematic review and a case-reports meta-analysis. Frontiers in Psychiatry. 15. 1371763–1371763.

Sabé, Michel, et al.. (2023). Neuropsychiatric disturbances in mild cognitive impairment: A scientometric analysis. Ageing Research Reviews. 92. 102129–102129. 11 indexed citations

10.

Sabé, Michel, Chaomei Chen, Joshua Hyde, et al.. (2023). A century of research on neuromodulation interventions: A scientometric analysis of trends and knowledge maps. Neuroscience & Biobehavioral Reviews. 152. 105300–105300. 24 indexed citations

11.

Sabé, Michel, Othman Sentissi, Françoise Jermann, et al.. (2023). Mindfulness-based interventions for patients with schizophrenia spectrum disorders: A systematic review of the literature. Schizophrenia Research. 264. 191–203. 11 indexed citations

12.

Solmi, Marco, Chaomei Chen, Anne Buot, et al.. (2022). A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs. European Neuropsychopharmacology. 64. 44–60. 33 indexed citations

13.

Sabé, Michel & Marco Solmi. (2022). The importance of evidence synthesis in psychopharmacology: Insights from a scientometric approach. European Neuropsychopharmacology. 61. 30–32. 1 indexed citations

14.

Sabé, Michel, Chaomei Chen, Marco Solmi, et al.. (2022). Thirty years of research on negative symptoms of schizophrenia: A scientometric analysis of hotspots, bursts, and research trends. Neuroscience & Biobehavioral Reviews. 144. 104979–104979. 52 indexed citations

15.

Sabé, Michel, Nan Zhao, & Stefan Kaiser. (2021). A systematic review and meta-analysis of the prevalence of cocaine-induced psychosis in cocaine users. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 109. 110263–110263. 16 indexed citations

16.

Sabé, Michel, Nan Zhao, Alessio Crippa, & Stefan Kaiser. (2021). Antipsychotics for negative and positive symptoms of schizophrenia: dose-response meta-analysis of randomized controlled acute phase trials. Schizophrenia. 7(1). 43–43. 41 indexed citations

17.

Sabé, Michel, Stefan Kaiser, & Gérard Niveau. (2020). Suicide in psychiatry and medical liability: A case series. International Journal of Law and Psychiatry. 74. 101671–101671. 2 indexed citations

18.

Sabé, Michel, Nan Zhao, & Stefan Kaiser. (2020). Cannabis, nicotine and the negative symptoms of schizophrenia: Systematic review and meta-analysis of observational studies. Neuroscience & Biobehavioral Reviews. 116. 415–425. 25 indexed citations

19.

Sabé, Michel, Matthias Kirschner, & Stefan Kaiser. (2019). Prodopaminergic Drugs for Treating the Negative Symptoms of Schizophrenia. Journal of Clinical Psychopharmacology. 39(6). 658–664. 18 indexed citations

20.

Sabé, Michel, Stefan Kaiser, & Othman Sentissi. (2019). Physical exercise for negative symptoms of schizophrenia: Systematic review of randomized controlled trials and meta-analysis. General Hospital Psychiatry. 62. 13–20. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact